YMH-15815-96598
3 vaccinations
8 coded responses
38 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 902 / CA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Moderna
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-10
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Moderna
-
2021-02-06
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
-
2021-02-20
Survey response — day 14, dose 2MedDRA: Lymphadenopathy, Petechiae — Feeling: FairFree text: petechiae on arms and legs. Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Survey response — day 21, dose 2MedDRA: Petechiae — Feeling: GoodFree text: PetechiaeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-13
Survey response — day 35, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: GoodFree text: Huge eczema flare up. Worst one since childhoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — day 42, dose 2MedDRA: Eczema, Fatigue, Petechiae — Feeling: FairFree text: Fatigue, petechiae on legs and arms, severe eczemaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
-
2021-08-07
Survey response — 6 months, dose 2MedDRA: Petechiae — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Petechiae in my extremities. Started a little over a week post second dose of the COVID-19 vaccine, continued for about four months, resolved for about a month, and recently returned though milder than it was originallyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-12
-
2021-11-07
Dose 3 — Moderna
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Asthma, Dizziness, Wheezing — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Wheezing/asthma, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — days 1–6 daily, dose 3MedDRA: Pre-existing disease, Wheezing — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Wheezing/asthmaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2021-12-13
- 2021-12-19
- 2022-02-06
-
2022-05-08
Survey response — 6 months, dose 3MedDRA: Seizure — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: SeizureMedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-05-10
- 2022-05-10
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-06 | Moderna | |
| 3 | 2021-11-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | priority 2/3 | |
| 2021-01-12 | priority 2/3 | |
| 2021-08-07 | Unsuccessful | |
| 2022-05-08 | Unsuccessful |
Free text
Release 4 — day 14, dose 2
Symptoms: petechiae on arms and legs. Swollen lymph nodes
Release 4 — day 21, dose 2
Symptoms: Petechiae
Release 5 — day 35, dose 2
Symptoms: Huge eczema flare up. Worst one since childhood
Release 6 — day 42, dose 2
Symptoms: Fatigue, petechiae on legs and arms, severe eczema
Release 9 — 6 months, dose 2
Symptoms: Petechiae in my extremities. Started a little over a week post second dose of the COVID-19 vaccine, continued for about four months, resolved for about a month, and recently returned though milder than it was originally
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Wheezing/asthma, dizziness
Systemic reaction (other): Wheezing/asthma
Release 11 — 6 months, dose 3
Symptoms: Seizure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Petechiae | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Seizure | · | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release